[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)]

[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)] Abstract Text:

Emmanuel Guardiola,Franck Morschhauser,Jean-Jacques Zambrowski,Eric-Charles Antoine,Emmanuel Guardiola,Franck Morschhauser,Jean-Jacques Zambrowski,Eric-Charles Antoine,

Anaemia is one of the most dreaded complications among patients with malignant pathologies. Its causes can be varied and whatever its severity, the impact on the quality of life of the patient remains essential. However, the epidemiologic data concerning anaemia are very few in the literature. This is why we carried out a large national survey about the prevalence and the management of anaemia among patients with malignant diseases. The F-ACT (French Anaemia Cancer Treatment) study is a retrospective observational multicentric study conducted with 178 experts practicing in 112 centers or units treating patients with solid tumours and/or malignant haematological diseases. Control over one day standard of consultation for each questioned expert, 2 782 patients were enrolled, including 1 892 (68%) patient with solid tumour and 890 (27%) patient with malignant haematological disease. The median age was 61 years (range : 18-93 years) including 1 335 women (48%) and 1 447 men (52%). A the date of enrollment, the median level of haemoglobin (Hb) was 11,6 g/dl (range: 5,2-18,5 g/dl) and 44% of patient had a level of Hb < 11 g/dl. An anaemia was found in all the cancer localizations and whatever the stage or the therapeutic status of the disease. Approximately 2/3 of the anaemic patients received treatment by erythropoiesis stimulating agent (ESA) and approximately 17% of them did not receive any specific treatment for this anaemia. The median level of Hb at the introduction of the ESA was 10 g/dl. These results, compared with those reported in study ECAS (European Cancer Anaemia Survey) in 2001, seem to show an improvement in the management of anaemia and the use of the ESA, in particular an earlier introduction of this type of treatment since the appearance of anaemia.

[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)] Publishing Authors By Initials

E Guardiola,F Morschhauser,JJ Zambrowski,EC Antoine,E Guardiola,F Morschhauser,JJ Zambrowski,EC Antoine,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)] Journal Published:

PUBLICATION TYPE: Multicenter Study

Journal: Bulletin du cancer

VOLUME: 94

Page Numbers: 907-14

Journal Abbreviation:

ISSN: 1769-6917

DAY: 1

MONTH: Oct

YEAR: 2007

[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)] Information

Number of References:

LANGUAGE: fre

NlmUniqueID: 72416

[Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)] Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: [Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)] Information

Substance Name:

Registry Number:

Grant and Affiliation Information for [Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)]

AFFILIATION: CHU Jean Minjoz, Service oncologie médicale, 3, bd Fleming, 25030 Besançon Cedex. eguardiola@chu-besancon.fr

Country: France

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Bull Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Management of anaemia in patient with cancer: results of the F-ACT study French Anaemia Cancer Treatment Related Publications

• Acute respiratory disorders in the newborn. The lessons to be learnt.
• Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.
• Cardiac rhabdomyoma in infancy. A case report.
• Choriocarcinoma presenting as a ruptured tubal ectopic pregnancy.
• Contact tracing of passengers exposed to an extensively drug-resistant tuberculosis case during an air flight from Beirut to Paris, October 2006.
• DNA immunisation. New histochemical and morphometric data.
• Herpes simplex virus type 1 encephalitis associated with acute retinal necrosis syndrome in an immunocompetent patient.
• Not Available
• Obstruction of the duodenum by a preduodenal portal vein in situs inversus.
• Primary ovarian ectopic pregnancy with the use of an intrauterine contraceptive device.
• The archaeology of "plague".
• Use of radio-frequency ablation for the palliative treatment of sacral chordoma.
• [Critical considerations on uterine interposition.]
• [Curative corticotherapy of malignant postoperative hyperthermia & prevention of operative shock.]
• [Epidemics and catastrophes]
• [Hormone therapy in cancer of the breast.]
• [Hydrocortisone in general therapy; hydrocortisone with free alcohol function.]
• [In Process Citation]
• [Management of anaemia in patient with cancer: results of the F-ACT study (French Anaemia Cancer Treatment)]
• [Neurological and psychological studies of patients with sleeping sickness and their course]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [OPHTHALMOLOGIC ASSISTANCE IN THE SAHARA.]
• [Pneumoperitoneum, diagnostic method in hepatodiaphragmatic malformation and hepatic tumors.]
• [The outset of heart transplantation in Belgium or the conjunction of resolute patients, trustful cardiologists and surgeon ready to go ahead]